16 May 2019
Heidelberg Engineering has donated a Spectralis optical coherence tomography (OCT) device to the low vision service at the Royal National Institute of Blind People (RNIB).
The RNIB’s service, which has not previously had an OCT device, provides integrated optometric low vision and rehabilitation services to people living in Camden and Islington in London.
Specialist lead for eye health at the RNIB, Dr Louise Gow, said: “We are so very grateful to Heidelberg Engineering for the opportunity to use Spectralis and we hope that we are able to improve not only the experience of individuals within our service but to provide evidence of the importance of OCT imaging beyond screening in primary care and diagnosis in hospital settings.”
Dr Gow explained that the device provides a more accurate assessment of the causes of reduction in vision while avoiding the cost of unnecessary referrals.
“The OCT will clarify the prognosis for patients so that we can tailor the recalls for each individual. This means that those with more rapid change can be seen more frequently and those who have stable eye disease can be given longer recalls,” she said.
Pictured is Dr Louise Gow (standing) with clinical lead optometrist at the RNIB’s low vision and learning disability service, Dr Zahra Jessa.
The RNIB’s service, which has not previously had an OCT device, provides integrated optometric low vision and rehabilitation services to people living in Camden and Islington in London.
Specialist lead for eye health at the RNIB, Dr Louise Gow, said: “We are so very grateful to Heidelberg Engineering for the opportunity to use Spectralis and we hope that we are able to improve not only the experience of individuals within our service but to provide evidence of the importance of OCT imaging beyond screening in primary care and diagnosis in hospital settings.”
Dr Gow explained that the device provides a more accurate assessment of the causes of reduction in vision while avoiding the cost of unnecessary referrals.
“The OCT will clarify the prognosis for patients so that we can tailor the recalls for each individual. This means that those with more rapid change can be seen more frequently and those who have stable eye disease can be given longer recalls,” she said.
Pictured is Dr Louise Gow (standing) with clinical lead optometrist at the RNIB’s low vision and learning disability service, Dr Zahra Jessa.
Comments (0)
You must be logged in to join the discussion. Log in